
Medpace Holdings (MEDP) Stock Forecast & Price Target
Medpace Holdings (MEDP) Analyst Ratings
Bulls say
Medpace Holdings is anticipating a 200-300 basis points increase in passthrough revenues in the second half of the year, building on elevated levels experienced in the second quarter. The company reported robust first-quarter results, highlighted by higher request for proposal (RFP) volumes, which supports its optimistic outlook on business growth. Additionally, Medpace expects its book-to-bill ratio to exceed 1.15x in the third quarter, indicating strong demand and potential for continued revenue expansion.
Bears say
Medpace Holdings has experienced an increase in backlog cancellations, which have been at or above what it considers the normal range, although these cancellations dropped to the lower end of expectations in Q2. The company has indicated uncertainty regarding the growth prospects of Direct Service revenue and does not anticipate a significant decline in 2026, which may imply cautious management of future revenue expectations. Furthermore, updated adjusted EBITDA estimates for 2025 and 2026 suggest a limited increase, driven by ongoing hiring in direct service costs and a decline in passthrough revenue, reflecting potential cost pressures that may affect profitability.
This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.
Medpace Holdings (MEDP) Analyst Forecast & Price Prediction
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares